Modulation of MSL1 Abundance in Female Drosophila Contributes to the Sex Specificity of Dosage Compensation

Corresponding author: Mitzi I. Kuroda, Howard Hughes Medical Institute, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030., mkuroda{at}bcm.tmc.edu (E-mail).

Communicating editor: V. G. FINNERTY

Dosage compensation in Drosophila is the mechanism by which X-linked gene expression is made equal in males and females. Proper regulation of this process is critical to the survival of both sexes. Males must turn the male-specific lethal (msl)-mediated pathway of dosage compensation on and females must keep it off. The msl2 gene is the primary target of negative regulation in females. Preventing production of MSL2 protein is sufficient to prevent dosage compensation; however, ectopic expression of MSL2 protein in females is not sufficient to induce an insurmountable level of dosage compensation, suggesting that an additional component is limiting in females. A candidate for this limiting factor is MSL1, because the amount of MSL1 protein in females is reduced compared to males. We have identified two levels of negative regulation of msl1 in females. The predominant regulation is at the level of protein stability, while a second regulatory mechanism functions at the level of protein synthesis. Overcoming these control mechanisms by overexpressing both MSL1 and MSL2 in females results in 100% female-specific lethality.

This article has been cited by other articles:

				I. V. Kotlikova, O. V. Demakova, V. F. Semeshin, V. V. Shloma, L. V. Boldyreva, M. I. Kuroda, and I. F. Zhimulev The Drosophila Dosage Compensation Complex Binds to Polytene Chromosomes Independently of Developmental Changes in Transcription Genetics, February 1, 2006; 172(2): 963 - 974. [Abstract] [Full Text] [PDF]

				V. Morales, C. Regnard, A. Izzo, I. Vetter, and P. B. Becker The MRG Domain Mediates the Functional Integration of MSL3 into the Dosage Compensation Complex Mol. Cell. Biol., July 15, 2005; 25(14): 5947 - 5954. [Abstract] [Full Text] [PDF]

				C.-G. Lee, T. W. Reichman, T. Baik, and M. B. Mathews MLE Functions as a Transcriptional Regulator of the roX2 Gene J. Biol. Chem., November 12, 2004; 279(46): 47740 - 47745. [Abstract] [Full Text] [PDF]

				B. P. Rattner and V. H. Meller Drosophila Male-Specific Lethal 2 Protein Controls Sex-Specific Expression of the roX Genes Genetics, April 1, 2004; 166(4): 1825 - 1832. [Abstract] [Full Text] [PDF]

				A. J. Greenberg, J. L. Yanowitz, and P. Schedl The Drosophila GAGA Factor Is Required for Dosage Compensation in Males and for the Formation of the Male-Specific-Lethal Complex Chromatin Entry Site at 12DE Genetics, January 1, 2004; 166(1): 279 - 289. [Abstract] [Full Text] [PDF]

				R. L. Kelley and M. I. Kuroda The Drosophila roX1 RNA Gene Can Overcome Silent Chromatin by Recruiting the Male-Specific Lethal Dosage Compensation Complex Genetics, June 1, 2003; 164(2): 565 - 574. [Abstract] [Full Text] [PDF]

				H. Oh, Y. Park, and M. I. Kuroda Local spreading of MSL complexes from roX genes on the Drosophila X chromosome Genes & Dev., June 1, 2003; 17(11): 1334 - 1339. [Abstract] [Full Text] [PDF]

				Y. Park, R. L. Kelley, H. Oh, M. I. Kuroda, and V. H. Meller Extent of Chromatin Spreading Determined by roX RNA Recruitment of MSL Proteins Science, November 22, 2002; 298(5598): 1620 - 1623. [Abstract] [Full Text] [PDF]